Exome Asset Management’s Ascendis Pharma ASND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-43,849	Closed	-$6.55M	–	64
2024 Q3	$6.55M	Buy	43,849 +23,849	+119%	+$3.56M	4.43%	2
2024 Q2	$2.73M	Buy	+20,000	New	+$2.73M	2.43%	17